Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].

Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] - 1 Jan 2005

Smorodinova Iu V, Shcherbaniuk A I, Ryzhko I V, Moldavan I A

Abstract excerpt

The efficacy of isepamycin vs. other aminoglycosides was studied in vitro and on albino mice with experimental plague due to natural antigen valuable strains of the plague microbe and the pathogen variants deprived of the ability to produce the capsular antigen fraction I (FI- phenotype). The MICs of isepamycin for the strains of the plague microbe (20 FI+ and 20FI-) were 1.0-4.0 mg\l, that did not differ from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Anti-Bacterial Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Bacterial Proteins

Share to Gentamicins

Share to Mice, Inbred Strains

Share to Plague

Share to Yersinia pestis

Source

Identifiers

PMID: 17016907

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].PMID 17016907Read ↗

[Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].Semantic proximity Read ↗

[Ofloxacin efficacy in the prophylaxis and treatment of experimental plague due to antigen complete and defective strains of the pathogen].Semantic proximity Read ↗

[Doxycycline in the prevention of experimental plague induced by plague microbe variants].Semantic proximity Read ↗

[Characteristics of plague pathogen mutants, differing by pigment sorption signs].Semantic proximity Read ↗

[Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].Semantic proximity Read ↗

[Virulence of rifampicin and quinolone resistant mutants of strains of plague microbe with Fra+ and Fra- phenotypes].Semantic proximity Read ↗

[Formation of virulent antigen-modified mutants (Fra-, Fra-Tox-) of plague bacteria resistant to rifampicin and quinolones].Semantic proximity Read ↗

[Functional phenotypic variability in a plague pathogen and plague enzootics].Semantic proximity Read ↗

[Chromosomal resistance of plague agent to quinolones].Semantic proximity Read ↗

[Isolation and biological characterization of Legionella pneumophila mutants resistant to aminoglycoside antibotics and their protective action].Semantic proximity Read ↗

[Various properties of RifR mutants of the plague agent].Semantic proximity Read ↗

[Methods of diagnostics and differentiation of the plague agent: intraspecies differentiation of Yersinia pestis. Part II].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.